Metraipolis › archive › dc_715d6471eaed

Future-Proofing European Pharmaceutical Regulatory and Market Access Practices Based on EU Learnings from the COVID-19 Pandemic: Insights from… — Europe PMC PMID:40914772

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/40914772
DOI: 10.1007/s43441-[numero omesso]-2
License (as archived): solo-consultazione
Archived: 2026-10-09T22:30:37.285Z
SHA-256 of the archived text: 6eda1fa4a007527aa92aa94b05becc5bcdadea23caf3484efa2fa43a00261ecc
Stable URL of this page: https://metraipolis.com/documento/dc_715d6471eaed

How to cite

Future-Proofing European Pharmaceutical Regulatory and Market Access Practices Based on EU Learnings from the COVID-19 Pandemic: Insights from… — Europe PMC PMID:40914772 — Europe PMC (en), https://europepmc.org/article/MED/40914772 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_715d6471eaed (Metraipolis archive dc_715d6471eaed, sha256 6eda1fa4a007527aa92aa94b05becc5bcdadea23caf3484efa2fa43a00261ecc)

BibTeX

@misc{dc715d6471eaed,
  title = {Future-Proofing European Pharmaceutical Regulatory and Market Access Practices Based on EU Learnings from the COVID-19 Pandemic: Insights from… — Europe PMC PMID:40914772},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40914772},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_715d6471eaed; sha256 6eda1fa4a007527aa92aa94b05becc5bcdadea23caf3484efa2fa43a00261ecc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40914772. Agents can read the archived copy with the MCP tool read_document.